A systematic review and meta-analysis published in JAMA Network Open looks at daily step counts and depression symptoms in adults. Dr Brendon Stubbs, NIHR Advanced Fellow, King’s College London (KCL), ...
Scientists comment on new legislation on regulatory frameworks for clinical trials, as laid out by UK Parliament. Dr Catriona Manville, Director of Research Policy at the Association of Medical ...
A study published in The Lancet Oncology looks at colorectal cancer incidence in young and older adults. Dr Sarah Bailey, NIHR Advanced Fellow, University of Exeter Medical School, said: ...
“The authors found that milk chocolate consumption was associated with weight gain, whereas dark chocolate intake was not. Weight gain is an important risk factor for type 2 diabetes development, so ...
A study published in Science looks at a mutation in bovine influenza (H5N1) hemagglutinin (HA) which could switch binding specificity to human receptors. Prof Ian Brown, Dr Thomas Peacock and Prof ...
Scientists comment on the government’s junk food advertising ban legislation. Prof Sarah Berry, Professor of Nutritional Sciences, King’s College London, said: ...
A cohort study published in Communications Medicine looks at effects of long Covid in children and young people over two years. Prof Peter Openshaw, Professor of Experimental Medicine and Dr Claudia ...
Scientists comment on an unknown illness in the Democratic Republic of Congo (DRC).
‘Device-measured vigorous intermittent lifestyle physical activity (VILPA) and major adverse cardiovascular events: evidence of sex differences’ by Stamatakis et al. was published in British Journal ...
Scientists comment on UKHSA announcing that the UK has secured doses of the human H5 influenza vaccine. Dr Ed Hutchinson, Senior Lecturer, MRC-University of Glasgow Centre for Virus Research (MRC CVR) ...
“3-NOP has properties which indicate that it can irritate the eyes and skin. It will be produced in particle sizes which will not penetrate the lungs, but if inhaled will affect the upper airways. Any ...
“We welcome the new guidance from NICE on overweight and obesity management and the recommendations for widening access to Tirzepatide for weight loss, which now includes rolling out to people with ...